Eli Lilly's dominance in the GLP-1 market and strong revenue growth forecast make LLY stock a promising investment, with a ...

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 494.50% and ...

A new request by Ozempic manufacturer Novo Nordisk could limit the availability of a type of GLP-1—semaglutides—to local ...

The Dow Jones Industrial Average lost 696.75 points, or 1.63%, to close at 41,938.45. The S&P 500 slid 1.54% to 5,827.04, ...

Semaglutide is helping patients achieve weight loss previously achievable only with bariatric surgery. But at what cost?

Prices for the top 25 brand-name Medicare Part D drugs have increased by an average of 98% since entering the market, ...

AbbVie said it would take a $3.5 billion dollar impairment charge related to the failure of a drug it acquired in its ...

In 2025, seniors will pay less for 64 medications if they get them through Medicare Part B, which covers outpatient care, ...